Diametric Capital »

Catalyst Pharmaceutical Partners shares owned by Diametric Capital

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Diametric Capital from 13F filings

Historical chart of Diametric Capital investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Diametric Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $617k 27k 23.34
2023-09-30 $372k 32k 11.69
2019-06-30 $195k 51k 3.85

More positions owned by Diametric Capital

Precigen (PGEN)
Harrow Health (HROW)
Bitmine Immersion Tecnologie Com New (BMNR)
Janone (ALTS)
Red Rock Resorts Cl A (RRR)
Fulgent Genetics (FLGT)
Golar Lng SHS (GLNG)
Brinker International (EAT)
MGM Resorts International. (MGM)
Telephone & Data Sys Com New (TDS)
Wynn Resorts (WYNN)
Brightstar Lottery Shs Usd (BRSL)
Asp Isotopes (ASPI)
Abeona Therapeutics Com New (ABEO)
Warner Bros Discovery Com Ser A (WBD)

View all positions for Diametric Capital

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Fundsmith
American Century Companies
Dimensional Fund Advisors
Geode Capital Management
Renaissance Technologies
Royce & Associates
Arrowstreet Capital, Limited Partnership
Millennium Management
Charles Schwab Investment Management
Invesco
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners